Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

DANI RAN CASTILLO

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1427570332
CMS profile
11306593
Location
DUARTE, CA

General Payments · PY2021–2024

$2,944.00

  • Reported across 36 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,871.96

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $1,471.48 2
Food and Beverage $400.48 14

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $223.91 2
PY2022 $358.93 4
PY2023 $489.20 14
PY2024 $1,871.96 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ADC Therapeutics America, Inc. $76.17 06/03/2024 Food and Beverage Undisputed 01/23/2026 1121193649 CMS
Amgen Inc. $735.74 05/15/2024 Consulting Fee Undisputed 01/23/2026 1117522501 CMS
Amgen Inc. $735.74 11/05/2024 Consulting Fee Undisputed 01/23/2026 1117522503 CMS
Astellas Pharma US Inc $15.17 01/18/2024 Food and Beverage Undisputed 01/23/2026 1139277144 CMS
Daiichi Sankyo Inc. $29.50 09/05/2024 Food and Beverage Undisputed 01/23/2026 1089406848 CMS
E.R. Squibb & Sons, L.L.C. $23.96 05/21/2024 Food and Beverage Undisputed 01/23/2026 1101666868 CMS
Eisai Inc. $21.84 03/11/2024 Food and Beverage Undisputed 01/23/2026 1110738153 CMS
Eisai Inc. $24.90 07/16/2024 Food and Beverage Undisputed 01/23/2026 1110738155 CMS
Incyte Corporation $24.51 06/06/2024 Food and Beverage Undisputed 01/23/2026 1141292010 CMS
Novartis Pharmaceuticals Corporation $26.68 07/23/2024 Food and Beverage Undisputed 01/23/2026 1086771205 CMS
Novartis Pharmaceuticals Corporation $16.79 08/27/2024 Food and Beverage Undisputed 01/23/2026 1086771207 CMS
Novartis Pharmaceuticals Corporation $22.06 09/23/2024 Food and Beverage Undisputed 01/23/2026 1086771209 CMS
Takeda Pharmaceuticals U.S.A., Inc. $34.95 05/02/2024 Food and Beverage Undisputed 01/23/2026 1144954665 CMS
Tempus AI, Inc $24.40 01/25/2024 Food and Beverage Undisputed 01/23/2026 1150162185 CMS
Tempus AI, Inc $28.97 05/28/2024 Food and Beverage Undisputed 01/23/2026 1150162187 CMS
TerSera Therapeutics LLC $30.58 03/20/2024 Food and Beverage Undisputed 01/23/2026 1144713639 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.